BIO-RAD LABORATORIES, INC. (NYSE:BIO) Files An 8-K Results of Operations and Financial Condition
ITEM 2.02 Results of Operations and Financial Condition
BIO-RAD LABORATORIES, INC. (NYSE:BIO) Files An 8-K Results of Operations and Financial Condition
On May 8, 2019, Bio-Rad Laboratories, Inc. announced its financial results for the quarter ended March 31, 2019. A copy of the press release is furnished as Exhibit 99.1 to this report.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
ITEM 9.01 Financial Statements and Exhibits
BIO-RAD LABORATORIES, INC. Exhibit
EX-99.1 2 bio-8k582019xex991.htm EXHIBIT 99.1 Exhibit Exhibit 99.1Press ReleaseBio-Rad Reports First Quarter 2019 Financial Results HERCULES,…
To view the full exhibit click
EX-99.1 2 bio-8k582019xex991.htm EXHIBIT 99.1 Exhibit Exhibit 99.1Press ReleaseBio-Rad Reports First Quarter 2019 Financial Results HERCULES,…
To view the full exhibit click
hereAbout BIO-RAD LABORATORIES, INC. (NYSE:BIO)
Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of life science research and clinical diagnostics products. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company’s Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Company’s Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. Bio-Rad sells over 8,000 products and services to a client base consisting of scientific research, healthcare, education and government customers around the world.
